01
Cash & equivalents decreased 65.6%
Cash & equivalents changed -65.6% from the comparable as-filed period.
$45.4M→$15.6MComparable → current
· Pharmaceutical Preparations
RESEARCH SNAPSHOTSeres Therapeutics, Inc.'s latest supported as-filed period reports revenue of $736,000. Every value below links to its SEC accession and metric lineage.
The most important deterministic changes, ranked by magnitude, issuer history, persistence, and accounting profile.
Cash & equivalents changed -65.6% from the comparable as-filed period.
Net income changed +123.1% from the comparable as-filed period.
Operating income changed +14.5% from the comparable as-filed period.
Research & development changed -29.4% from the comparable as-filed period.
Each point keeps the date investors could first observe it and its accession.
MCRB · as filed with the SEC · reported-date aware
Direct SEC links, filing dates, report periods, and amendment flags.
0001193125-26-355734SEC ↗4Aug 18, 2026Period Aug 15, 20260001193125-26-355722SEC ↗4Aug 18, 2026Period Aug 15, 20260001193125-26-355718SEC ↗4Aug 18, 2026Period Aug 15, 20260001193125-26-355712SEC ↗10-QAug 5, 2026Period Jun 30, 20260001193125-26-334174SEC ↗8-KAug 5, 2026Period Aug 5, 20260001193125-26-333820SEC ↗8-KAug 4, 2026Period Jul 31, 20260001193125-26-332742SEC ↗Transaction semantics distinguish purchases, sales, awards, exercises, withholding, and derivatives.
| Filed / transacted | Reporting owner | Semantics | Shares | Price | Notional | Source |
|---|---|---|---|---|---|---|
| Aug 17, 2026Filed Aug 18, 2026 | Brady KellySee Remarks | Open Market SaleDirect | 64 | $5 | $291 | Form 4 ↗ |
| Aug 15, 2026Filed Aug 18, 2026 | Brady KellySee Remarks | Option ExerciseDirect | 181 | — | — | Form 4 ↗ |
| Aug 15, 2026Filed Aug 18, 2026 | Brady KellySee Remarks | Option ExerciseDirect | 90 | $0 | $0 | Form 4 ↗ |
| Aug 15, 2026Filed Aug 18, 2026 | Brady KellySee Remarks | Option ExerciseDirect | 91 | $0 | $0 | Form 4 ↗ |
GrossPattern stores immutable raw artifacts, accession-scoped facts, parser and metric versions, dependency edges, quality state, and channel-specific publication rights. A restricted or unknown ancestor blocks the page and API automatically.
SEC source policy ↗Stock-based compensation changed -25.7% from the comparable as-filed period.
Method note “Materiality” here is an analytical magnitude band, not a legal conclusion. Full filing-text semantic changes remain unpublished while excerpt rights and review thresholds are unresolved.
Latest supported period in this snapshot: 2026-06-30. Duration facts use direct quarterly or annual SEC contexts; GrossPattern does not manufacture missing Q4 values.
0001193125-26-300927